Analysis, article raise questions about Gardasil's safety

A safety analysis conducted by the FDA and the CDC links Merck & Co.'s cervical cancer vaccine Gardasil to 1,900 reports of fainting and 56 incidents of blood clots. Also, a medical article written by Columbia University researchers criticizes Merck's marketing strategy for the drug, saying it failed to address "the full complexity of the issues surrounding the vaccine and did not provide balanced recommendations on risks and benefits."

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR